Jeremy Green's Net Worth

$747 Million

Estimate Recalculated Feb 22, 2024 04:24PM EST

Who is Jeremy Green?

Jeremy Green has an estimated net worth of $747 Million. This is based on reported shares across multiple companies, which include ALDER BIOPHARMACEUTICALS INC, XERIS PHARMACEUTICALS INC, RayzeBio, Inc., Allakos Inc., Science 37 Holdings, Inc., PLIANT THERAPEUTICS, INC., Stoke Therapeutics, Inc., Absci Corp, Adagio Therapeutics, Inc., Gritstone Oncology, Inc., Entrada Therapeutics, Inc., Repare Therapeutics Inc., Allovir, Inc., IGM Biosciences, Inc., Verve Therapeutics, Inc., Nurix Therapeutics, Inc., Akero Therapeutics, Inc., Replimune Group, Inc., AMICUS THERAPEUTICS INC, FATE THERAPEUTICS INC, Kymera Therapeutics, Inc., Beam Therapeutics Inc., Augmedix, Inc., Neoleukin Therapeutics, Inc., Syros Pharmaceuticals, Inc., Atreca, Inc., VAPOTHERM INC, Shattuck Labs, Inc., TCR2 THERAPEUTICS INC., HOOKIPA Pharma Inc., Cabaletta Bio, Inc., Annexon, Inc., MedAvail Holdings, Inc., Aprea Therapeutics, Inc., ARRAY BIOPHARMA INC, and Zymeworks Inc..

SEC CIK

Jeremy Green's CIK is 0001650527

Past Insider Trading and Trends

2020 was Jeremy Green's most active year for acquiring shares with 41 total transactions. Jeremy Green's most active month to acquire stocks was the month of May. 2019 was Jeremy Green's most active year for disposing of shares, totalling 18 transactions. Jeremy Green's most active month to dispose stocks was the month of September. 2020 saw Jeremy Green paying a total of $190,530,705.65 for 23,089,273 shares, this is the most they've acquired in one year. In 2023 Jeremy Green cashed out on 20,855,459 shares for a total of $77,321,731.46, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALDER BIOPHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-8.24M
0
Oct 22
Form 4
0
0
Jun 30
Form 4
0
0
May 23
Form 4
+26.73%
1.74M
$11.50
$19,999,995.00
8.24M
Mar 4
Form 4
0
0
Dec 31
Form 4
0
0
Jun 30
Form 4
0
0
May 23
Form 4
0
0
Apr 25
Form 3
0
0
No matching records found

XERIS PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+24.37%
588K
$10.00
$5,880,000.00
3M
Feb 19
Form 4
2.41M
$15.00
2.41M
Jun 25
Form 3
0
0
No matching records found

RayzeBio, Inc. (RYZB) Snapshot price: $62.13

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.86M
1.86M
Sep 19
Form 3
0
0
No matching records found

Allakos Inc. (ALLK) Snapshot price: $1.262

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.01M
1.01M
Jul 23
Form 3
0
0
No matching records found

Science 37 Holdings, Inc. (SNCE) Snapshot price: $5.66

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2.49%
494.85K
$0.25
$124,999.87
20.34M
May 11
Form 4
0
$3.38
39.7M
Jun 13
Form 4
+0.21%
40.98K
$3.05
$124,998.15
19.85M
May 23
Form 4/A
+296.16%
14.81M
19.81M
Oct 6
Form 4
0
0
Oct 7
Form 4
+295.02%
14.75M
19.75M
Oct 6
Form 3
0
0
No matching records found